查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球细胞分离/细胞分离市场：按产品类型（消耗品,设备）,细胞类型（人体/动物细胞）,细胞来源（骨髓,组织）,技术（离心机）,应用,最终用户（製药公司）至2028
市场调查报告书
商品编码
1280706

全球细胞分离/细胞分离市场：按产品类型（消耗品,设备）,细胞类型（人体/动物细胞）,细胞来源（骨髓,组织）,技术（离心机）,应用,最终用户（製药公司）至2028

Cell Isolation/ Cell Separation Market by Product (Consumables, Instruments), Cell Type (Human Cells, Animal Cells), Cell Source (Bone Marrow, Adipose Tissues), Technique (Centrifugation-based), Application, End User (Pharma) - Global Forecast to 2028
出版日期: | 出版商: MarketsandMarkets | 英文 309 Pages | 订单完成后即时交付

价格
简介目录

全球细胞分离市场规模预计到 2028 年将达到 82 亿美元，高于 2023 年的 44 亿美元，预测期内復合年增长率为 13.4%。

增加对基于细胞的研究的资助等因素正在加速市场的增长。 慢性病和传染病发病率的增加增加了对新治疗方式的需求，例如需要细胞分离技术的细胞疗法。 新的和先进的细胞分离技术的发展，如基于微流体的细胞分选,磁激活细胞分选和荧光激活细胞分选，正在推动市场的增长。 政府和私人组织也大力投资于生命科学和生物技术研究，推动了对细胞分离产品和技术的需求。

“消耗品细分市场在预测期内（2023 年至 2028 年）将以最高复合年增长率增长”

按产品划分，消耗品部分预计在预测期内以最高复合年增长率增长。 这种增长是由于细胞研究中对耗材的需求增加。 预计这将对分部增长产生积极影响。 耗材可以减少手动细胞分离程序的需要，从而节省时间。 这在时间紧迫的应用领域尤其重要，例如临床环境。 可以适应各种实验条件和细胞类型，允许定制协议以满足研究人员的需要。 耗材可以降低分离过程中的污染风险，对于保持分离细胞的完整性很重要。 耗材通常设计为与各种下游应用领域兼容，例如基因表达分析和蛋白质组学。

“2023年人体细胞领域将占据压倒性份额”

由于对人体细胞研究的投资不断增加，预计人体细胞部分将在预测期内占据主导地位。 HeLa 细胞等人类细胞系已用于研究数十年，并已成为许多医学研究领域的重要工具。 已建立的细胞系的可用性使研究人员更容易获得和研究人类细胞。 通过提供更准确的人体生理学和疾病表征，在研究中使用人体细胞可以促进研究成果从实验室转移到临床。 在研究中使用人类细胞通常比使用动物细胞更容易被接受。 这是因为人类细胞被认为更相关且争议更少。

“预测期内（2023-2028 年）骨髓部分将以最高复合年增长率增长”

按细胞来源划分，骨髓部分预计在预测期内以最高复合年增长率增长。 由于骨髓含有多种细胞群，包括造血干细胞,间充质干细胞和免疫细胞，因此用于各种治疗应用的骨髓干细胞产品的商业化是增长的关键驱动力。它是 这些细胞可以被分离并用于广泛的应用，包括研究,药物发现和基于细胞的治疗。 多年来，骨髓细胞分离已经得到很好的建立和标准化，使研究人员可以随时获得高质量的细胞。

“在预测期内（2023-2028 年），表面标记表达的细胞分离部分将以最高复合年增长率增长”

根据技术，预计在预测期内表达表面标记的细胞分离将以最高复合年增长率增长。 这种增长归因于製药行业对这项技术的需求不断增加。 预计这将推动部门增长。

“2022年，生物分子分离板块占据压倒性份额”

从应用来看，生物分子分离领域占有压倒性的份额。

“在预测期内 (2023-2028)，製药和生物技术领域将以最高复合年增长率增长”

在最终用户方面，预计製药和生物技术公司细分市场在预测期内将以最高复合年增长率增长。 製药和生物技术公司对研发活动的日益关注是预测市场增长的关键因素之一。

“亚太地区增长速度更快”

到 2022 年，北美将主导细胞分离市场。 该地区的主导地位源于多种因素，包括该地区占主导地位的大公司的存在以及技术进步。 由于人口增长和政府改善医疗基础设施的努力等多种因素，预计亚太地区将以更快的速度增长。

内容

第一章介绍

第二章研究方法论

第 3 章执行摘要

第 4 章重要注意事项

第 5 章市场概述

  • 介绍
  • 市场动态
    • 司机
    • 约束因素
    • 机会
    • 任务
  • 影响客户业务的趋势/颠覆
  • 价格分析
  • 价值链分析
  • 生态系统分析
  • 监管分析
  • 波特的五力分析
  • 主要会议和活动 (2023-2024)
  • 技术分析
  • 主要利益相关者和采购标准
  • 贸易分析
  • 专利分析

第 6 章细胞分离市场：按产品分类

  • 介绍
  • 消耗品
    • 试剂,试剂盒,培养基,血清
    • 珠子
    • 一次性用品
  • 设备
    • 离心机
    • 细胞分选员
    • 磁性激活细胞分选系统
    • 过滤系统

第 7 章细胞分离市场：按细胞类型分类

  • 介绍
  • 人体细胞
    • 分化细胞
    • 干细胞
  • 动物细胞

第 8 章细胞分离市场：按细胞来源分类

  • 介绍
  • 骨髓
  • 脂肪组织
  • 脐带血/胚胎干细胞
  • 其他细胞来源

第 9 章细胞分离市场：按技术分类

  • 介绍
  • 离心细胞分离
  • 基于表面标记的细胞分离
  • 过滤细胞分离

第 10 章细胞分离市场：按应用

  • 介绍
  • 生物分子的分离
  • 癌症研究
  • 干细胞研究
  • 组织再生和再生医学
  • 体外诊断
  • 其他用途

第 11 章细胞分离市场：按最终用户分类

  • 介绍
  • 製药和生物技术公司
  • 学术和研究机构
  • 医院和诊断实验室
  • 其他最终用户

第 12 章细胞分离市场：按地区

  • 介绍
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳大利亚
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲

第13章竞争格局

  • 介绍
  • 主要公司采用的策略
  • 市场份额分析
  • 利润分析
  • 公司评估矩阵
  • 前 25 家公司的竞争基准
  • 初创公司/中小企业的业务评估矩阵
  • 竞争情景和趋势

第14章公司简介

  • 主要公司
    • THERMO FISHER SCIENTIFIC, INC.
    • BECTON, DICKINSON AND COMPANY (BD)
    • DANAHER CORPORATION
    • MERCK KGAA
    • TERUMO CORPORATION
    • AGILENT TECHNOLOGIES, INC.
    • BIO-RAD LABORATORIES, INC.
    • CORNING INCORPORATED
    • F. HOFFMANN-LA ROCHE LTD.
    • ALFA LAVAL
    • MILTENYI BIOTEC
    • SARTORIUS AG
    • STEMCELL TECHNOLOGIES
    • AKADEUM LIFE SCIENCES
    • BIO-TECHNE
  • 其他企业
    • TAKARA BIO INC.
    • QIAGEN
    • LONZA GROUP
    • PERKINELMER INC. (BIOLEGEND, INC.)
    • PROMEGA CORPORATION
    • PROTEINTECH GROUP, INC.
    • PLURISELECT LIFE SCIENCE UG (HAFTUNGSBESCHRANKT) & CO. KG
    • INVENT BIOTECHNOLOGIES, INC.
    • MICAREO INC.
    • MAGBIO GENOMICS

第15章 附录

简介目录
Product Code: BT 2757

The global cell isolation market size is projected to reach USD 8.2 billion by 2028 from USD 4.4 billion in 2023, at a CAGR of 13.4% during the forecast period. Factors such as increasing funding for cell-based research, are driving the market growth at a faster pace. The incidence of chronic and infectious diseases is on the rise, which is driving the demand for new therapies, including cell-based therapies that require cell isolation technologies. The development of new and advanced cell isolation technologies, such as microfluidics-based cell sorting, magnetic-activated cell sorting, and fluorescence-activated cell sorting, is driving the growth of the market. Governments and private organizations are investing heavily in life sciences and biotechnology research, which is driving the demand for cell isolation products and technologies.

"The consumables segment is likely to grow at highest CAGR during the forecast period of 2023-2028."

On the basis of product, the cell isolation market is segmented into consumables and instruments. The consumables segment is projected to grow at the highest CAGR during the forecast period. The growth is attributed to increasing demand of consumables in cell based research. This is likely to have a positive impact on segmental growth. Consumables can save time by reducing the need for manual cell isolation procedures. This can be especially important for applications where time is critical, such as in clinical settings. Consumables can be adapted to different experimental conditions and cell types, allowing researchers to customize their protocols to their specific needs. Consumables can reduce the risk of contamination during the isolation process, which is important for maintaining the integrity of the isolated cells. Consumables are often designed to be compatible with a range of downstream applications, such as gene expression analysis and proteomics.

"The human cells segment is expected to hold a dominant share in 2023."

Based on the cell type, the market is segmented into human cells, and animal cells. The human cells segment is expected to hold a dominant share during the forecast period due to increasing investments for the research on human cells. Human cell lines, such as HeLa cells, have been used in research for decades and have become an important tool in many areas of medical research. The availability of established cell lines makes it easier for researchers to obtain and study human cells. The use of human cells in research can facilitate the translation of findings from the laboratory to the clinic, as human cells provide a more accurate representation of human physiology and disease. The use of human cells in research is generally more accepted by the public than the use of animal cells, as human cells are seen as more relevant and less controversial.

"The bone marrow cell isolation segment is likely to grow at highest CAGR during the forecast period of 2023-2028."

On the basis of cell source, the cell isolation market is segmented into adipose tissue, bone marrow, and cord blood/embryonic stem cells, and other cell sources. The bone marrow segment is projected to grow at the highest CAGR during the forecast period. The growth is attributed to commercialization of a number of bone marrow-derived stem cell-based products for various therapeutic applications.Bone marrow contains a diverse population of cells, including hematopoietic stem cells, mesenchymal stem cells, and immune cells. These cells can be isolated and used in a wide range of applications, including research, drug discovery, and cell-based therapies. The isolation of bone marrow cells has been well-established and standardized over the years, making it easier for researchers to obtain high-quality cells.

"The surface-marker based cell isolation segment is likely to grow at highest CAGR during the forecast period of 2023-2028."

On the basis of technique, the cell isolation market is segmented into centrifugation-based cell isolation, surface-marker based cell isolation, and filtration-based cell isolation. The surface-marker based isolation segment is projected to grow at the highest CAGR during the forecast period. The growth is attributed to increasing demand of this technique in the pharmaceutical industries. This is likely to propel segmental growth.

"In 2022, the biomolecule isolation segment held a dominant share."

Based on application, the cell isolation market is segmented into biomolecule isolation, stem cell research, cancer research, in vitro diagnostics, and tissue regeneration & regenerative medicine, and other applications. The biomolecule isolation segment held a dominant share of the cell isolation market. Technological advancements to project the market growth.

"The pharmaceutical & biotechnology companies segment is likely to grow at highest CAGR during the forecast period of 2023-2028."

Based on end user, the cell isolation market is segmented into pharmaceutical & biotechnology companies, academic and research institutes, hospitals and diagnostic laboratories, and other end users. The pharmaceutical & biotechnology companies segment to grow at the highest CAGR during the forecast period. Pharmaceutical and biotechnology companies' focus on R&D activities is one of the major factors anticipated to project market growth.

"Asia Pacific region is likely to grow at faster pace."

The cell isolation market is divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2022, North America accounted for the dominant share of cell isolation market. The dominance of the region is attributable to various factors such as the presence of dominant & key market players in the region, and technological advancements. Asia Pacific region is likely to grow at a faster pace owing to various factors such as the growing population, and government initiatives for infrastructural improvements of healthcare facilities are driving market growth in this region.

The primary interviews conducted for this report can be categorized as follows:

  • By Respondent: Supply Side- 80%, and Demand Side - 20%
  • By Designation (Supply Side): Managers - 35%, CXOs & Directors - 20%, Executives- 45%
  • By Region: North America -25%, Europe -30%, Asia-Pacific -30%, Latin America -10%, and Middle East and Africa -5%

Lists of Companies Profiled in the Report:

  • Danaher Corporation (US)
  • Merck KGaA (Germany)
  • Thermo Fisher Scientific, Inc. (US)
  • Becton, Dickinson and Company (US)
  • Terumo Corporation (Japan)
  • Agilent Technologies, Inc. (US)
  • Bio-Rad Laboratories, Inc. (US)
  • Corning Incorporated (US)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Miltenyi Biotec (Germany)
  • STEMCELL Technologies (Canada)
  • Alfa Laval (Sweden)
  • Sartorius AG (Germany)
  • Akadeum Life Sciences (US)
  • Bio-Techne (US)
  • PerkinElmer Inc. (US)
  • Invent Biotechnologies, Inc. (US)
  • Takara Bio, Inc. (Japan)
  • MiCareo Inc. (US)
  • Proteintech Group, Inc. (US)
  • QIAGEN (Germany)
  • Lonza (Switzerland)
  • Promega Corporation (US)
  • PluriSelect Life Science UG (Haftungsbeschrankt) & Co. KG (Germany)
  • MagBio Genomics (US)

Research Coverage:

This report provides a detailed picture of the cell isolation market. It aims at estimating the size and future growth potential of the market across different segments, such as product, cell type, cell source, technique, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall single-use bioreactors market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, challenges, trends, and opportunities.

The report provides insights on the following pointers:

  • Analysis of key drivers (Increasing government funding for cell-based research, increasing number of patients suffering from cancer and infectious diseases, technological advancements), restraints (Ethical & safety issues related to embryonic stem cell isolation, high cost of cell-based research), opportunities (Growth opportunities in emerging markets) and challenges (Obstacles to develop cell therapies) influencing the growth of cell isolation market.
  • Product Development/Innovation: Detailed insights on newly launched products, and technological assessment of the cell isolation market.
  • Market Development: Comprehensive information about lucrative markets - the report analyses the cell isolation market across varied regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell isolation market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies and product offerings of leading players in the cell isolation market. The report also helps stakeholders understand the pulse of single-use bioreactors market and provides them information on key market drivers, restraints, challenges, and opportunities along with market trends.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
  • 1.3 MARKET SCOPE
    • FIGURE 1 CELL ISOLATION MARKET SEGMENTATION
    • 1.3.1 YEARS CONSIDERED
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES
    • 1.7.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH APPROACH
    • FIGURE 2 RESEARCH DESIGN
    • 2.1.1 SECONDARY RESEARCH
    • 2.1.2 PRIMARY RESEARCH
    • FIGURE 3 CELL ISOLATION MARKET: PRIMARY RESPONDENTS
  • 2.2 MARKET ESTIMATION METHODOLOGY
    • FIGURE 4 MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS, 2022
    • FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2022
    • FIGURE 6 MARKET SIZE ESTIMATION: APPROACH 2 (TOP-DOWN-BASED ESTIMATION), 2022
    • 2.2.1 INSIGHTS FROM PRIMARY EXPERTS
    • FIGURE 7 INSIGHTS ON CELL ISOLATION MARKET FROM PRIMARY EXPERTS
  • 2.3 MARKET GROWTH RATE PROJECTIONS
    • FIGURE 8 CELL ISOLATION MARKET: CAGR PROJECTIONS, 2023-2028
    • FIGURE 9 CELL ISOLATION MARKET (DEMAND SIDE): GROWTH ANALYSIS OF DEMAND-SIDE FACTORS
  • 2.4 DATA TRIANGULATION
    • FIGURE 10 DATA TRIANGULATION METHODOLOGY
  • 2.5 RESEARCH ASSUMPTIONS
  • 2.6 RISK ANALYSIS
  • 2.7 RECESSION IMPACT
    • TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021-2027 (% GROWTH)

3 EXECUTIVE SUMMARY

    • FIGURE 11 CELL ISOLATION MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
    • FIGURE 12 CELL ISOLATION MARKET, BY CELL TYPE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 13 CELL ISOLATION MARKET, BY CELL SOURCE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 14 CELL ISOLATION MARKET, BY TECHNIQUE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 15 CELL ISOLATION MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
    • FIGURE 16 CELL ISOLATION MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    • FIGURE 17 GEOGRAPHICAL SNAPSHOT OF CELL ISOLATION MARKET

4 PREMIUM INSIGHTS

  • 4.1 CELL ISOLATION MARKET OVERVIEW
    • FIGURE 18 INCREASING FUNDING FOR CELL-BASED RESEARCH TO DRIVE GROWTH
  • 4.2 NORTH AMERICA: CELL ISOLATION MARKET, BY PRODUCT AND COUNTRY (2022)
    • FIGURE 19 CONSUMABLES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
  • 4.3 CELL ISOLATION MARKET SHARE, BY APPLICATION, 2023 VS. 2028
    • FIGURE 20 BIOMOLECULE ISOLATION SEGMENT TO CONTINUE TO DOMINATE MARKET IN 2028
  • 4.4 CELL ISOLATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 21 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 22 CELL ISOLATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • TABLE 2 CELL ISOLATION MARKET: IMPACT ANALYSIS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing government funding for cell-based research
    • TABLE 3 NIH FUNDING FOR CELL-BASED RESEARCH, 2019-2022 (USD MILLION)
      • 5.2.1.2 Increasing number of patients suffering from cancer and infectious diseases
    • TABLE 4 INCIDENCE OF CANCER, BY REGION, 2020
    • TABLE 5 IMPORTANT STATISTICS ON INFECTIOUS DISEASES
      • 5.2.1.3 Technological advancements
      • 5.2.1.4 Growing focus on personalized medicine
    • TABLE 6 FDA APPROVAL RATE FOR PERSONALIZED MEDICINES, 2015-2021
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Ethical & safety issues related to embryonic stem cell isolation
      • 5.2.2.2 High cost of cell-based research
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growth opportunities in emerging markets
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Obstacles to developing cell therapies
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
    • FIGURE 23 REVENUE SHIFT AND NEW REVENUE POCKETS
  • 5.4 PRICING ANALYSIS
    • TABLE 7 PRICE OF KEY CELL ISOLATION PRODUCTS OF KEY COMPANIES (2022)
  • 5.5 VALUE CHAIN ANALYSIS
    • FIGURE 24 CELL ISOLATION MARKET: VALUE CHAIN ANALYSIS
  • 5.6 ECOSYSTEM ANALYSIS
    • TABLE 8 CELL ISOLATION MARKET ECOSYSTEM
  • 5.7 REGULATORY ANALYSIS
  • 5.8 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 9 CELL ISOLATION/ CELL SEPARATION MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.8.1 THREAT FROM NEW ENTRANTS
    • 5.8.2 THREAT FROM SUBSTITUTES
    • 5.8.3 BARGAINING POWER OF SUPPLIERS
    • 5.8.4 BARGAINING POWER OF BUYERS
    • 5.8.5 DEGREE OF COMPETITION
  • 5.9 KEY CONFERENCES & EVENTS IN 2023-2024
    • TABLE 10 CELL ISOLATION MARKET: DETAILED LIST OF CONFERENCES & EVENTS
  • 5.10 TECHNOLOGY ANALYSIS
    • 5.10.1 MICROFLUIDICS
    • 5.10.2 MAGNETIC CELL ISOLATION
    • 5.10.3 FLUORESCENCE-ACTIVATED CELL SORTING (FACS)
    • 5.10.4 ACOUSTIC CELL ISOLATION
    • 5.10.5 ACOUSTO-FLUIDIC CELL ISOLATION
  • 5.11 KEY STAKEHOLDERS & BUYING CRITERIA
    • FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF CELL ISOLATION PRODUCTS
    • FIGURE 26 KEY BUYING CRITERIA FOR CELL ISOLATION PRODUCTS
  • 5.12 TRADE ANALYSIS
    • TABLE 11 EXPORT DATA (TOP 10 COUNTRIES)
    • TABLE 12 IMPORT DATA (TOP 10 COUNTRIES)
  • 5.13 PATENT ANALYSIS
    • FIGURE 27 PATENT APPLICATIONS RELATED TO CELL ISOLATION, JANUARY 2012-MARCH 2023
    • TABLE 13 LIST OF PATENTS IN CELL ISOLATION MARKET

6 CELL ISOLATION MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 14 CELL ISOLATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • 6.2 CONSUMABLES
    • TABLE 15 CELL ISOLATION CONSUMABLES MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 16 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 17 EUROPE: CELL ISOLATION CONSUMABLES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 18 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 19 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 20 CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 6.2.1 REAGENTS, KITS, MEDIA, AND SERA
      • 6.2.1.1 Disposable nature of reagents and assay kits to drive consistent usage and frequent purchases
    • TABLE 21 CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 22 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 23 EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 24 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 25 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.2.2 BEADS
    • TABLE 26 CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 27 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 28 EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 29 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 30 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 31 CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021-2028 (USD MILLION)
      • 6.2.2.1 Magnetic beads
        • 6.2.2.1.1 Growing demand for magnetic beads in T-cell and stem cell isolation to drive growth
    • TABLE 32 CELL ISOLATION CONSUMABLES MARKET FOR MAGNETIC BEADS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 33 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR MAGNETIC BEADS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 34 EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR MAGNETIC BEADS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 35 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR MAGNETIC BEADS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 36 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR MAGNETIC BEADS, BY COUNTRY, 2021-2028 (USD MILLION)
      • 6.2.2.2 Fluorescent beads
        • 6.2.2.2.1 Advantages of fluorescent beads to boost adoption
    • TABLE 37 CELL ISOLATION CONSUMABLES MARKET FOR FLUORESCENT BEADS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 38 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR FLUORESCENT BEADS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 39 EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR FLUORESCENT BEADS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 40 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR FLUORESCENT BEADS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 41 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR FLUORESCENT BEADS, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.2.3 DISPOSABLES
      • 6.2.3.1 Growing government investments in research to boost growth
    • TABLE 42 CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 43 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 44 EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 45 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 46 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.3 INSTRUMENTS
    • TABLE 47 CELL ISOLATION INSTRUMENTS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 48 NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 49 EUROPE: CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 50 ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 51 LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 52 CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 6.3.1 CENTRIFUGES
      • 6.3.1.1 Growing use of centrifuges in pharma-biotech industry to boost market
    • TABLE 53 CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 54 NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 55 EUROPE: CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 56 ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 57 LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.3.2 CELL SORTERS
      • 6.3.2.1 Launch of innovative and cost-effective cell sorters to support market
    • TABLE 58 CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 59 NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 60 EUROPE: CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 61 ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 62 LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.3.3 MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS
      • 6.3.3.1 Growing focus on personalized medicine to drive segmental growth
    • TABLE 63 CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 64 NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 65 EUROPE: CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 66 ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 67 LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.3.4 FILTRATION SYSTEMS
      • 6.3.4.1 Increasing research activities in cell biology to boost market
    • TABLE 68 CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 69 NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 70 EUROPE: CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 71 ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 72 LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2021-2028 (USD MILLION)

7 CELL ISOLATION MARKET, BY CELL TYPE

  • 7.1 INTRODUCTION
    • TABLE 73 CELL ISOLATION MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
  • 7.2 HUMAN CELLS
    • TABLE 74 CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 75 CELL ISOLATION MARKET FOR HUMAN CELLS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 76 NORTH AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 77 EUROPE: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 78 ASIA PACIFIC: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 79 LATIN AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
    • 7.2.1 DIFFERENTIATED CELLS
      • 7.2.1.1 Growing investments by market players to develop new and innovative products to support growth
    • TABLE 80 CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 81 NORTH AMERICA: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 82 EUROPE: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 83 ASIA PACIFIC: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 84 LATIN AMERICA: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
    • 7.2.2 STEM CELLS
      • 7.2.2.1 Rising government initiatives focused on supporting stem cell research to drive market
    • TABLE 85 CELL ISOLATION MARKET FOR STEM CELLS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 86 NORTH AMERICA: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 87 EUROPE: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 88 ASIA PACIFIC: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 89 LATIN AMERICA: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.3 ANIMAL CELLS
    • 7.3.1 INCREASING INVESTMENTS IN BIOPHARMACEUTICAL R&D FOR VACCINE AND DRUG DEVELOPMENT TO BOOST MARKET
    • TABLE 90 CELL ISOLATION MARKET FOR ANIMAL CELLS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 91 NORTH AMERICA: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 92 EUROPE: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 93 ASIA PACIFIC: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 94 LATIN AMERICA: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2021-2028 (USD MILLION)

8 CELL ISOLATION MARKET, BY CELL SOURCE

  • 8.1 INTRODUCTION
    • TABLE 95 CELL ISOLATION MARKET, BY CELL SOURCE, 2021-2028 (USD MILLION)
  • 8.2 BONE MARROW
    • 8.2.1 GROWING NUMBER OF COMMERCIALIZED BONE MARROW-DERIVED STEM CELLS TO DRIVE MARKET
    • TABLE 96 CELL ISOLATION MARKET FOR BONE MARROW-DERIVED CELLS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 97 NORTH AMERICA: CELL ISOLATION MARKET FOR BONE MARROW-DERIVED CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 98 EUROPE: CELL ISOLATION MARKET FOR BONE MARROW-DERIVED CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 99 ASIA PACIFIC: CELL ISOLATION MARKET FOR BONE MARROW-DERIVED CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 100 LATIN AMERICA: CELL ISOLATION MARKET FOR BONE MARROW-DERIVED CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.3 ADIPOSE TISSUE
    • 8.3.1 ABILITY OF ADIPOSE STEM/STROMAL CELLS TO GENERATE VARIETY OF OTHER CELL TYPES TO DRIVE DEMAND
    • TABLE 101 CELL ISOLATION MARKET FOR ADIPOSE TISSUE-DERIVED CELLS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 102 NORTH AMERICA: CELL ISOLATION MARKET FOR ADIPOSE TISSUE-DERIVED CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 103 EUROPE: CELL ISOLATION MARKET FOR ADIPOSE TISSUE-DERIVED CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 104 ASIA PACIFIC: CELL ISOLATION MARKET FOR ADIPOSE TISSUE-DERIVED CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 105 LATIN AMERICA: CELL ISOLATION MARKET FOR ADIPOSE TISSUE-DERIVED CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.4 CORD BLOOD/EMBRYONIC STEM CELLS
    • 8.4.1 HIGH THERAPEUTIC POTENCY OF CORD BLOOD/EMBRYONIC STEM CELLS TO SUPPORT MARKET
    • TABLE 106 CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 107 NORTH AMERICA: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 108 EUROPE: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 109 ASIA PACIFIC: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 110 LATIN AMERICA: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.5 OTHER CELL SOURCES
    • TABLE 111 CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 112 NORTH AMERICA: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 113 EUROPE: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 114 ASIA PACIFIC: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 115 LATIN AMERICA: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2021-2028 (USD MILLION)

9 CELL ISOLATION MARKET, BY TECHNIQUE

  • 9.1 INTRODUCTION
    • TABLE 116 CELL ISOLATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
  • 9.2 CENTRIFUGATION-BASED CELL ISOLATION
    • 9.2.1 COST-EFFECTIVENESS OF TECHNIQUE IN BOTH SMALL-SCALE AND LARGE-SCALE OPERATIONS TO DRIVE MARKET
    • TABLE 117 CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 118 NORTH AMERICA: CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 119 EUROPE: CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 120 ASIA PACIFIC: CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 121 LATIN AMERICA: CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.3 SURFACE MARKER-BASED CELL ISOLATION
    • 9.3.1 WIDE USAGE IN BIOPHARMACEUTICAL AND BIOTECH INDUSTRIES TO SUPPORT GROWTH
    • TABLE 122 SURFACE MARKER-BASED CELL ISOLATION MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 123 NORTH AMERICA: SURFACE MARKER-BASED CELL ISOLATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 124 EUROPE: SURFACE MARKER-BASED CELL ISOLATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 125 ASIA PACIFIC: SURFACE MARKER-BASED CELL ISOLATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 126 LATIN AMERICA: SURFACE MARKER-BASED CELL ISOLATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.4 FILTRATION-BASED CELL ISOLATION
    • 9.4.1 LOW COST OF FILTRATION TECHNIQUE TO BOOST ADOPTION
    • TABLE 127 FILTRATION-BASED CELL ISOLATION MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 128 NORTH AMERICA: FILTRATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 129 EUROPE: FILTRATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 130 ASIA PACIFIC: FILTRATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 131 LATIN AMERICA: FILTRATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)

10 CELL ISOLATION MARKET, BY APPLICATION

  • 10.1 INTRODUCTION
    • TABLE 132 CELL ISOLATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • 10.2 BIOMOLECULE ISOLATION
    • 10.2.1 BIOMOLECULE ISOLATION SEGMENT TO DOMINATE CELL ISOLATION MARKET DURING FORECAST PERIOD
    • TABLE 133 CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 134 NORTH AMERICA: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 135 EUROPE: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 136 ASIA PACIFIC: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 137 LATIN AMERICA: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 10.3 CANCER RESEARCH
    • 10.3.1 HIGH DISEASE INCIDENCE TO FUEL DEMAND FOR ADVANCED TREATMENTS
    • TABLE 138 CELL ISOLATION MARKET FOR CANCER RESEARCH APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 139 NORTH AMERICA: CELL ISOLATION MARKET FOR CANCER RESEARCH APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 140 EUROPE: CELL ISOLATION MARKET FOR CANCER RESEARCH APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 141 ASIA PACIFIC: CELL ISOLATION MARKET FOR CANCER RESEARCH APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 142 LATIN AMERICA: CELL ISOLATION MARKET FOR CANCER RESEARCH APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 10.4 STEM CELL RESEARCH
    • 10.4.1 INCREASING FUNDING IN STEM CELL RESEARCH TO SUPPORT MARKET GROWTH
    • TABLE 143 CELL ISOLATION MARKET FOR STEM CELL RESEARCH APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 144 NORTH AMERICA: CELL ISOLATION MARKET FOR STEM CELL RESEARCH APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 145 EUROPE: CELL ISOLATION MARKET FOR STEM CELL RESEARCH APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 146 ASIA PACIFIC: CELL ISOLATION MARKET FOR STEM CELL RESEARCH APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 147 LATIN AMERICA: CELL ISOLATION MARKET FOR STEM CELL RESEARCH APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 10.5 TISSUE REGENERATION & REGENERATIVE MEDICINE
    • 10.5.1 GROWING REGENERATIVE MEDICINE INITIATIVES TO SUPPORT MARKET
    • TABLE 148 CELL ISOLATION MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 149 NORTH AMERICA: CELL ISOLATION MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 150 EUROPE: CELL ISOLATION MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 151 ASIA PACIFIC: CELL ISOLATION MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 152 LATIN AMERICA: CELL ISOLATION MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 10.6 IN VITRO DIAGNOSTICS
    • 10.6.1 RISING DISEASE INCIDENCE TO DRIVE DEMAND FOR INNOVATIVE THERAPIES AND DIAGNOSTICS
    • TABLE 153 CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTIC APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 154 NORTH AMERICA: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 155 EUROPE: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 156 ASIA PACIFIC: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 157 LATIN AMERICA: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 10.7 OTHER APPLICATIONS
    • TABLE 158 CELL ISOLATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 159 NORTH AMERICA: CELL ISOLATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 160 EUROPE: CELL ISOLATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 161 ASIA PACIFIC: CELL ISOLATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 162 LATIN AMERICA: CELL ISOLATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)

11 CELL ISOLATION MARKET, BY END USER

  • 11.1 INTRODUCTION
    • TABLE 163 CELL ISOLATION MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 11.2.1 FAVORABLE R&D INVESTMENTS TO BOOST MARKET GROWTH
    • TABLE 164 CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 165 NORTH AMERICA: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 166 EUROPE: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 167 ASIA PACIFIC: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 168 LATIN AMERICA: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 11.3 ACADEMIC & RESEARCH INSTITUTES
    • 11.3.1 RISING FUNDING FOR CELL-BASED RESEARCH TO DRIVE MARKET GROWTH
    • TABLE 169 CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 170 NORTH AMERICA: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 171 EUROPE: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 172 ASIA PACIFIC: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 173 LATIN AMERICA: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 11.4 HOSPITALS & DIAGNOSTIC LABORATORIES
    • 11.4.1 INCREASING NUMBER OF HOSPITALS IN EMERGING COUNTRIES TO CONTRIBUTE TO MARKET GROWTH
    • TABLE 174 CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 175 NORTH AMERICA: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 176 EUROPE: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 177 ASIA PACIFIC: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 178 LATIN AMERICA: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 11.5 OTHER END USERS
    • TABLE 179 CELL ISOLATION MARKET FOR OTHER END USERS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 180 NORTH AMERICA: CELL ISOLATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 181 EUROPE: CELL ISOLATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 182 ASIA PACIFIC: CELL ISOLATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 183 LATIN AMERICA: CELL ISOLATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)

12 CELL ISOLATION MARKET, BY REGION

  • 12.1 INTRODUCTION
    • TABLE 184 CELL ISOLATION MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 12.2 NORTH AMERICA
    • FIGURE 28 NORTH AMERICA: CELL ISOLATION MARKET SNAPSHOT
    • TABLE 185 NORTH AMERICA: CELL ISOLATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 186 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 187 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 188 NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 189 NORTH AMERICA: CELL ISOLATION MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 190 NORTH AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 191 NORTH AMERICA: CELL ISOLATION MARKET, BY CELL SOURCE, 2021-2028 (USD MILLION)
    • TABLE 192 NORTH AMERICA: CELL ISOLATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 193 NORTH AMERICA: CELL ISOLATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 194 NORTH AMERICA: CELL ISOLATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.2.1 US
      • 12.2.1.1 US to dominate North American cell isolation market during forecast period
    • TABLE 195 US: CELL ISOLATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 196 US: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 197 US: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 198 US: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 199 US: CELL ISOLATION MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 200 US: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 201 US: CELL ISOLATION MARKET, BY CELL SOURCE, 2021-2028 (USD MILLION)
    • TABLE 202 US: CELL ISOLATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 203 US: CELL ISOLATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 204 US: CELL ISOLATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.2.2 CANADA
      • 12.2.2.1 Increasing funding for research in regenerative medicine to support market growth in Canada
    • TABLE 205 CANADA: CELL ISOLATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 206 CANADA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 207 CANADA: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 208 CANADA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 209 CANADA: CELL ISOLATION MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 210 CANADA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 211 CANADA: CELL ISOLATION MARKET, BY CELL SOURCE, 2021-2028 (USD MILLION)
    • TABLE 212 CANADA: CELL ISOLATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 213 CANADA: CELL ISOLATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 214 CANADA: CELL ISOLATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.2.3 NORTH AMERICA: RECESSION IMPACT
  • 12.3 EUROPE
    • TABLE 215 EUROPE: CELL ISOLATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 216 EUROPE: CELL ISOLATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 217 EUROPE: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 218 EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 219 EUROPE: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 220 EUROPE: CELL ISOLATION MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 221 EUROPE: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 222 EUROPE: CELL ISOLATION MARKET, BY CELL SOURCE, 2021-2028 (USD MILLION)
    • TABLE 223 EUROPE: CELL ISOLATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 224 EUROPE: CELL ISOLATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 225 EUROPE: CELL ISOLATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.3.1 GERMANY
      • 12.3.1.1 Germany to be fastest-growing market for cell isolation in Europe
    • TABLE 226 GERMANY: CELL ISOLATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 227 GERMANY: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 228 GERMANY: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 229 GERMANY: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 230 GERMANY: CELL ISOLATION MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 231 GERMANY: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 232 GERMANY: CELL ISOLATION MARKET, BY CELL SOURCE, 2021-2028 (USD MILLION)
    • TABLE 233 GERMANY: CELL ISOLATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 234 GERMANY: CELL ISOLATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 235 GERMANY: CELL ISOLATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.3.2 UK
      • 12.3.2.1 Government investments in stem cell research to drive market for cell isolation in UK
    • TABLE 236 UK: CELL ISOLATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 237 UK: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 238 UK: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 239 UK: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 240 UK: CELL ISOLATION MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 241 UK: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 242 UK: CELL ISOLATION MARKET, BY CELL SOURCE, 2021-2028 (USD MILLION)
    • TABLE 243 UK: CELL ISOLATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 244 UK: CELL ISOLATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 245 UK: CELL ISOLATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.3.3 FRANCE
      • 12.3.3.1 Increasing prevalence of various chronic and infectious diseases to drive market growth
    • TABLE 246 FRANCE: CELL ISOLATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 247 FRANCE: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 248 FRANCE: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 249 FRANCE: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 250 FRANCE: CELL ISOLATION MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 251 FRANCE: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 252 FRANCE: CELL ISOLATION MARKET, BY CELL SOURCE, 2021-2028 (USD MILLION)
    • TABLE 253 FRANCE: CELL ISOLATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 254 FRANCE: CELL ISOLATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 255 FRANCE: CELL ISOLATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.3.4 ITALY
      • 12.3.4.1 Increasing number of cell biology seminars and conferences to fuel adoption of cell isolation products
    • TABLE 256 ITALY: CELL ISOLATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 257 ITALY: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 258 ITALY: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 259 ITALY: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 260 ITALY: CELL ISOLATION MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 261 ITALY: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 262 ITALY: CELL ISOLATION MARKET, BY CELL SOURCE, 2021-2028 (USD MILLION)
    • TABLE 263 ITALY: CELL ISOLATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 264 ITALY: CELL ISOLATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 265 ITALY: CELL ISOLATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.3.5 SPAIN
      • 12.3.5.1 Increasing funding from private and public organizations to aid growth
    • TABLE 266 SPAIN: CELL ISOLATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 267 SPAIN: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 268 SPAIN: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 269 SPAIN: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 270 SPAIN: CELL ISOLATION MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 271 SPAIN: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 272 SPAIN: CELL ISOLATION MARKET, BY CELL SOURCE, 2021-2028 (USD MILLION)
    • TABLE 273 SPAIN: CELL ISOLATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 274 SPAIN: CELL ISOLATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 275 SPAIN: CELL ISOLATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.3.6 REST OF EUROPE
    • TABLE 276 REST OF EUROPE: CELL ISOLATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 277 REST OF EUROPE: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 278 REST OF EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 279 REST OF EUROPE: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 280 REST OF EUROPE: CELL ISOLATION MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 281 REST OF EUROPE: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 282 REST OF EUROPE: CELL ISOLATION MARKET, BY CELL SOURCE, 2021-2028 (USD MILLION)
    • TABLE 283 REST OF EUROPE: CELL ISOLATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 284 REST OF EUROPE: CELL ISOLATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 285 REST OF EUROPE: CELL ISOLATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.3.7 EUROPE: RECESSION IMPACT
  • 12.4 ASIA PACIFIC
    • FIGURE 29 ASIA PACIFIC: CELL ISOLATION MARKET SNAPSHOT
    • TABLE 286 ASIA PACIFIC: CELL ISOLATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 287 ASIA PACIFIC: CELL ISOLATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 288 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 289 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 290 ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 291 ASIA PACIFIC: CELL ISOLATION MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 292 ASIA PACIFIC: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 293 ASIA PACIFIC: CELL ISOLATION MARKET, BY CELL SOURCE, 2021-2028 (USD MILLION)
    • TABLE 294 ASIA PACIFIC: CELL ISOLATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 295 ASIA PACIFIC: CELL ISOLATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 296 ASIA PACIFIC: CELL ISOLATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.4.1 CHINA
      • 12.4.1.1 Growing cell therapy-based research in China to boost market
    • TABLE 297 CHINA: CELL ISOLATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 298 CHINA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 299 CHINA: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 300 CHINA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 301 CHINA: CELL ISOLATION MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 302 CHINA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 303 CHINA: CELL ISOLATION MARKET, BY CELL SOURCE, 2021-2028 (USD MILLION)
    • TABLE 304 CHINA: CELL ISOLATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 305 CHINA: CELL ISOLATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 306 CHINA: CELL ISOLATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.4.2 JAPAN
      • 12.4.2.1 Increasing geriatric population and subsequent rise in prevalence of chronic diseases to drive market
    • TABLE 307 JAPAN: CELL ISOLATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 308 JAPAN: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 309 JAPAN: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 310 JAPAN: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 311 JAPAN: CELL ISOLATION MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 312 JAPAN: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 313 JAPAN: CELL ISOLATION MARKET, BY CELL SOURCE, 2021-2028 (USD MILLION)
    • TABLE 314 JAPAN: CELL ISOLATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 315 JAPAN: CELL ISOLATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 316 JAPAN: CELL ISOLATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.4.3 INDIA
      • 12.4.3.1 Rising incidence of chronic and infectious diseases to drive demand for cell isolation products
    • TABLE 317 INDIA: CELL ISOLATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 318 INDIA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 319 INDIA: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 320 INDIA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 321 INDIA: CELL ISOLATION MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 322 INDIA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 323 INDIA: CELL ISOLATION MARKET, BY CELL SOURCE, 2021-2028 (USD MILLION)
    • TABLE 324 INDIA: CELL ISOLATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 325 INDIA: CELL ISOLATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 326 INDIA: CELL ISOLATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.4.4 AUSTRALIA
      • 12.4.4.1 Rising stem cell research to drive demand for cell isolation products
    • TABLE 327 AUSTRALIA: CELL ISOLATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 328 AUSTRALIA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 329 AUSTRALIA: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 330 AUSTRALIA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 331 AUSTRALIA: CELL ISOLATION MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 332 AUSTRALIA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 333 AUSTRALIA: CELL ISOLATION MARKET, BY CELL SOURCE, 2021-2028 (USD MILLION)
    • TABLE 334 AUSTRALIA: CELL ISOLATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 335 AUSTRALIA: CELL ISOLATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 336 AUSTRALIA: CELL ISOLATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.4.5 REST OF ASIA PACIFIC
    • TABLE 337 REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 338 REST OF ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 339 REST OF ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 340 REST OF ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 341 REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 342 REST OF ASIA PACIFIC: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 343 REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY CELL SOURCE, 2021-2028 (USD MILLION)
    • TABLE 344 REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 345 REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 346 REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.4.6 ASIA PACIFIC: RECESSION IMPACT
  • 12.5 LATIN AMERICA
    • TABLE 347 LATIN AMERICA: CELL ISOLATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 348 LATIN AMERICA: CELL ISOLATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 349 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 350 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 351 LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 352 LATIN AMERICA: CELL ISOLATION MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 353 LATIN AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 354 LATIN AMERICA: CELL ISOLATION MARKET, BY CELL SOURCE, 2021-2028 (USD MILLION)
    • TABLE 355 LATIN AMERICA: CELL ISOLATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 356 LATIN AMERICA: CELL ISOLATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 357 LATIN AMERICA: CELL ISOLATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.5.1 BRAZIL
      • 12.5.1.1 Expansion of leading market players in country to drive market growth
    • TABLE 358 BRAZIL: CELL ISOLATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 359 BRAZIL: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 360 BRAZIL: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 361 BRAZIL: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 362 BRAZIL: CELL ISOLATION MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 363 BRAZIL: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 364 BRAZIL CELL ISOLATION MARKET, BY CELL SOURCE, 2021-2028 (USD MILLION)
    • TABLE 365 BRAZIL: CELL ISOLATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 366 BRAZIL: CELL ISOLATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 367 BRAZIL: CELL ISOLATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.5.2 REST OF LATIN AMERICA
    • TABLE 368 REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 369 REST OF LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 370 REST OF LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 371 REST OF LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 372 REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 373 REST OF LATIN AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 374 REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY CELL SOURCE, 2021-2028 (USD MILLION)
    • TABLE 375 REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 376 REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 377 REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.5.3 LATIN AMERICA: RECESSION IMPACT
  • 12.6 MIDDLE EAST & AFRICA
    • 12.6.1 GROWING PHARMACEUTICAL INDUSTRY IN MEA TO DRIVE MARKET GROWTH
    • TABLE 378 MIDDLE EAST & AFRICA: CELL ISOLATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 379 MIDDLE EAST & AFRICA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 380 MIDDLE EAST & AFRICA: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 381 MIDDLE EAST & AFRICA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 382 MIDDLE EAST & AFRICA: CELL ISOLATION MARKET, BY CELL TYPE, 2021-2028 (USD MILLION)
    • TABLE 383 MIDDLE EAST & AFRICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 384 MIDDLE EAST & AFRICA: CELL ISOLATION MARKET, BY CELL SOURCE, 2021-2028 (USD MILLION)
    • TABLE 385 MIDDLE EAST & AFRICA: CELL ISOLATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 386 MIDDLE EAST & AFRICA: CELL ISOLATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 387 MIDDLE EAST & AFRICA: CELL ISOLATION MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 12.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT

13 COMPETITIVE LANDSCAPE

  • 13.1 INTRODUCTION
  • 13.2 STRATEGIES ADOPTED BY KEY PLAYERS
    • FIGURE 30 CELL ISOLATION MARKET: STRATEGIES ADOPTED
  • 13.3 MARKET SHARE ANALYSIS
    • FIGURE 31 CELL ISOLATION MARKET: MARKET SHARE ANALYSIS, BY KEY PLAYER (2022)
    • TABLE 388 CELL ISOLATION MARKET: DEGREE OF COMPETITION
  • 13.4 REVENUE ANALYSIS
    • FIGURE 32 CELL ISOLATION MARKET: REVENUE ANALYSIS, BY KEY PLAYER (2020-2022)
  • 13.5 COMPANY EVALUATION MATRIX
    • FIGURE 33 CELL ISOLATION MARKET: COMPANY EVALUATION MATRIX, 2022
    • 13.5.1 STARS
    • 13.5.2 EMERGING LEADERS
    • 13.5.3 PERVASIVE PLAYERS
    • 13.5.4 PARTICIPANTS
  • 13.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS
    • 13.6.1 OVERALL COMPANY FOOTPRINT (25 COMPANIES)
    • TABLE 389 END-USER, PRODUCT, AND REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS
    • 13.6.2 END-USER FOOTPRINT OF COMPANIES (25 COMPANIES)
    • TABLE 390 END-USER FOOTPRINT ANALYSIS OF KEY PLAYERS
    • 13.6.3 REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES)
    • TABLE 391 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS
    • 13.6.4 PRODUCT FOOTPRINT OF COMPANIES (25 COMPANIES)
    • TABLE 392 PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS
  • 13.7 COMPANY EVALUATION MATRIX FOR START-UPS/SMES
    • FIGURE 34 CELL ISOLATION MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022
    • 13.7.1 PROGRESSIVE COMPANIES
    • 13.7.2 STARTING BLOCKS
    • 13.7.3 RESPONSIVE COMPANIES
    • 13.7.4 DYNAMIC COMPANIES
    • 13.7.5 COMPETITIVE BENCHMARKING OF START-UPS/SMES
    • TABLE 393 CELL ISOLATION MARKET: DETAILED LIST OF KEY START-UPS/SMES
    • TABLE 394 CELL ISOLATION MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SMES
  • 13.8 COMPETITIVE SCENARIO AND TRENDS
    • 13.8.1 PRODUCT LAUNCHES
    • TABLE 395 CELL ISOLATION MARKET: PRODUCT LAUNCHES, JANUARY 2020-MAY 2023
    • 13.8.2 DEALS
    • TABLE 396 CELL ISOLATION MARKET: DEALS, JANUARY 2020-MAY 2023
    • 13.8.3 OTHER DEVELOPMENTS
    • TABLE 397 CELL ISOLATION MARKET: OTHER DEVELOPMENTS, JANUARY 2020-MAY 2023

14 COMPANY PROFILES

  • 14.1 KEY PLAYERS
  • (Business Overview, Products offered, Recent Developments, MnM View)**
    • 14.1.1 THERMO FISHER SCIENTIFIC, INC.
    • TABLE 398 THERMO FISHER SCIENTIFIC, INC.: COMPANY OVERVIEW
    • FIGURE 35 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2022)
    • 14.1.2 BECTON, DICKINSON AND COMPANY (BD)
    • TABLE 399 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
    • FIGURE 36 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)
    • 14.1.3 DANAHER CORPORATION
    • TABLE 400 DANAHER CORPORATION: COMPANY OVERVIEW
    • FIGURE 37 DANAHER CORPORATION: COMPANY SNAPSHOT (2022)
    • 14.1.4 MERCK KGAA
    • TABLE 401 MERCK KGAA: COMPANY OVERVIEW
    • FIGURE 38 MERCK KGAA: COMPANY SNAPSHOT (2022)
    • 14.1.5 TERUMO CORPORATION
    • TABLE 402 TERUMO CORPORATION: COMPANY OVERVIEW
    • FIGURE 39 TERUMO CORPORATION: COMPANY SNAPSHOT (2022)
    • 14.1.6 AGILENT TECHNOLOGIES, INC.
    • TABLE 403 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
    • FIGURE 40 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2022)
    • 14.1.7 BIO-RAD LABORATORIES, INC.
    • TABLE 404 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
    • FIGURE 41 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022)
    • 14.1.8 CORNING INCORPORATED
    • TABLE 405 CORNING INCORPORATED: COMPANY OVERVIEW
    • FIGURE 42 CORNING INCORPORATED: COMPANY SNAPSHOT (2022)
    • 14.1.9 F. HOFFMANN-LA ROCHE LTD.
    • TABLE 406 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
    • FIGURE 43 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2022)
    • 14.1.10 ALFA LAVAL
    • TABLE 407 ALFA LAVAL: COMPANY OVERVIEW
    • FIGURE 44 ALFA LAVAL: COMPANY SNAPSHOT (2022)
    • 14.1.11 MILTENYI BIOTEC
    • TABLE 408 MILTENYI BIOTEC: COMPANY OVERVIEW
    • 14.1.12 SARTORIUS AG
    • TABLE 409 SARTORIUS AG: COMPANY OVERVIEW
    • FIGURE 45 SARTORIUS AG: COMPANY SNAPSHOT (2022)
    • 14.1.13 STEMCELL TECHNOLOGIES
    • TABLE 410 STEMCELL TECHNOLOGIES: COMPANY OVERVIEW
    • 14.1.14 AKADEUM LIFE SCIENCES
    • TABLE 411 AKADEUM LIFE SCIENCES: COMPANY OVERVIEW
    • 14.1.15 BIO-TECHNE
    • TABLE 412 BIO-TECHNE: COMPANY OVERVIEW
    • FIGURE 46 BIO-TECHNE: COMPANY SNAPSHOT (2022)
  • 14.2 OTHER COMPANIES
    • 14.2.1 TAKARA BIO INC.
    • 14.2.2 QIAGEN
    • 14.2.3 LONZA GROUP
    • 14.2.4 PERKINELMER INC. (BIOLEGEND, INC.)
    • 14.2.5 PROMEGA CORPORATION
    • 14.2.6 PROTEINTECH GROUP, INC.
    • 14.2.7 PLURISELECT LIFE SCIENCE UG (HAFTUNGSBESCHRANKT) & CO. KG
    • 14.2.8 INVENT BIOTECHNOLOGIES, INC.
    • 14.2.9 MICAREO INC.
    • 14.2.10 MAGBIO GENOMICS
  • *Details on Business Overview, Products offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

15 APPENDIX

  • 15.1 DISCUSSION GUIDE
  • 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 15.3 CUSTOMIZATION OPTIONS
  • 15.4 RELATED REPORTS
  • 15.5 AUTHOR DETAILS